Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (52472) 52472
Newsletter (8836) 8836
Book Review (8146) 8146
Publication (4142) 4142
Newspaper Article (3601) 3601
Conference Proceeding (375) 375
Book Chapter (358) 358
Trade Publication Article (129) 129
Dissertation (127) 127
Book / eBook (114) 114
Magazine Article (92) 92
Web Resource (19) 19
Reference (17) 17
Transcript (10) 10
Data Set (4) 4
Paper (2) 2
Government Document (1) 1
Poster (1) 1
Presentation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (38699) 38699
pancreatic cancer (36441) 36441
humans (36004) 36004
cancer (21331) 21331
male (18481) 18481
female (18453) 18453
oncology (16700) 16700
middle aged (15287) 15287
pancreatic neoplasms - pathology (14816) 14816
aged (14129) 14129
research (13471) 13471
adenocarcinoma (12061) 12061
surgery (9996) 9996
adult (9560) 9560
animals (8090) 8090
tumors (7663) 7663
metastasis (7638) 7638
prognosis (7518) 7518
gastroenterology & hepatology (7226) 7226
care and treatment (7086) 7086
pancreatic neoplasms - surgery (6866) 6866
oncology, experimental (6734) 6734
chemotherapy (6726) 6726
carcinoma (6455) 6455
pancreas (6408) 6408
aged, 80 and over (5765) 5765
analysis (5571) 5571
pancreatic neoplasms - genetics (5527) 5527
pancreatic neoplasms - metabolism (5368) 5368
cell line, tumor (5277) 5277
adenocarcinoma - pathology (5190) 5190
pancreatic neoplasms - drug therapy (5145) 5145
expression (5073) 5073
survival (5048) 5048
diagnosis (4839) 4839
mice (4831) 4831
health aspects (4775) 4775
pancreatic neoplasms - diagnosis (4712) 4712
medicine & public health (4634) 4634
gemcitabine (4604) 4604
abridged index medicus (4471) 4471
pancreatic neoplasms - mortality (4183) 4183
retrospective studies (4182) 4182
genetic aspects (4079) 4079
pancreatic-cancer (4075) 4075
treatment outcome (3893) 3893
reports (3839) 3839
apoptosis (3814) 3814
pancreaticoduodenectomy (3781) 3781
carcinoma, pancreatic ductal - pathology (3702) 3702
immunohistochemistry (3652) 3652
development and progression (3581) 3581
ductal adenocarcinoma (3454) 3454
proteins (3437) 3437
cancer therapies (3378) 3378
medical research (3356) 3356
gene expression (3340) 3340
pathology (3247) 3247
risk factors (3209) 3209
medical prognosis (3153) 3153
cell biology (3109) 3109
pancreatic neoplasms - therapy (3023) 3023
neoplasm staging (2975) 2975
adenocarcinoma - surgery (2858) 2858
article (2845) 2845
deoxycytidine - analogs & derivatives (2721) 2721
gastroenterology (2721) 2721
pancreatic neoplasms - diagnostic imaging (2690) 2690
patients (2662) 2662
survival rate (2529) 2529
breast-cancer (2467) 2467
pancreatic ductal adenocarcinoma (2459) 2459
mutation (2401) 2401
survival analysis (2389) 2389
mortality (2368) 2368
studies (2359) 2359
therapy (2336) 2336
resection (2332) 2332
pancreatectomy (2297) 2297
gene expression regulation, neoplastic (2294) 2294
cells (2267) 2267
biochemistry & molecular biology (2234) 2234
adenocarcinoma - drug therapy (2176) 2176
pancreatic adenocarcinoma (2136) 2136
clinical trials (2116) 2116
gastroenterology and hepatology (2113) 2113
radiology, nuclear medicine & medical imaging (2106) 2106
medicine (2094) 2094
diagnosis, differential (2062) 2062
tomography, x-ray computed (2059) 2059
growth (2042) 2042
signal transduction (1994) 1994
pancreas - pathology (1983) 1983
cell proliferation (1976) 1976
pancreatitis (1966) 1966
follow-up studies (1964) 1964
neoplasm invasiveness (1954) 1954
drug therapy (1910) 1910
adenocarcinoma - mortality (1883) 1883
universities and colleges (1874) 1874
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (65) 65
Collection Dvlpm't (Acquisitions) - Closed Orders (5) 5
Online Resources - Online (4) 4
Collection Dvlpm't (Acquisitions) - Vendor file (2) 2
Scarborough Hospital - General (1) 1
Sunnybrook Health Sciences Centre - Online (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (62777) 62777
Japanese (664) 664
German (598) 598
French (573) 573
Spanish (279) 279
Chinese (170) 170
Korean (131) 131
Russian (119) 119
Italian (117) 117
Polish (52) 52
Czech (35) 35
Portuguese (28) 28
Hungarian (23) 23
Romanian (18) 18
Bulgarian (15) 15
Danish (15) 15
Turkish (14) 14
Dutch (13) 13
Ukrainian (8) 8
Croatian (6) 6
Finnish (5) 5
Hebrew (4) 4
Norwegian (4) 4
Serbian (3) 3
Slovak (3) 3
Bosnian (2) 2
Catalan (2) 2
Latvian (2) 2
Lithuanian (2) 2
Persian (2) 2
Estonian (1) 1
Greek (1) 1
Slovenian (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Metabolic and morphological measurements of subcutaneous and visceral fat and their relationship with disease stage and overall survival in newly diagnosed pancreatic adenocarcinoma: Metabolic and morphological fat measurements in pancreatic adenocarcinoma
by Van de Wiele, Christophe and Van Vlaenderen, Mathias and D’Hulst, Ludovic and Delcourt, Anne and Copin, Dominique and De Spiegeleer, Bart and Maes, Alex
European Journal of Nuclear Medicine and Molecular Imaging, ISSN 1619-7070, 01/2017, Volume 44, Issue 1, pp. 110 - 116
Purpose The relationship between tumor metabolism and stage, subcutaneous and visceral fat thickness, and their glucose metabolism and overall survival in... 
Fat | Pancreatic adenocarcinoma | Disease stage | Survival | CANCER CACHEXIA | CELLS | WEIGHT-LOSS | OBESITY | LIPOLYSIS | LIPOGENESIS | INFLAMMATION | PET/CT | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | ADIPOSE-TISSUE | Fluorodeoxyglucose F18 - pharmacokinetics | Adenocarcinoma - pathology | Pancreatic Neoplasms - metabolism | Prevalence | Early Detection of Cancer - methods | Humans | Middle Aged | Subcutaneous Fat - diagnostic imaging | Male | Abdominal Fat - diagnostic imaging | Subcutaneous Fat - metabolism | Adenocarcinoma - metabolism | Sensitivity and Specificity | Aged, 80 and over | Adult | Female | Pancreatic Neoplasms - mortality | Radiopharmaceuticals | Positron Emission Tomography Computed Tomography - statistics & numerical data | Early Detection of Cancer - statistics & numerical data | Positron Emission Tomography Computed Tomography - methods | Reproducibility of Results | Abdominal Fat - pathology | Pancreatic Neoplasms - pathology | Risk Factors | Survival Rate | Intra-Abdominal Fat - metabolism | Subcutaneous Fat - pathology | Intra-Abdominal Fat - diagnostic imaging | Abdominal Fat - metabolism | Biomarkers | Aged | Intra-Abdominal Fat - pathology | Neoplasm Staging | Adenocarcinoma - mortality | Survival analysis | Body fat | Metabolism | Morphology | Pancreatic cancer
Journal Article
Details down arrow
2. Pancreatic Adenocarcinoma
by Tempero, MA and Arnoletti, JP and Behrman, S and Ben-Josef, E and Benson, AB and Berlin, JD and Cameron, JL and Casper, ES and Cohen, SJ and Duff, M and Ellenhorn, JDI and Hawkins, WG and Hoffman, JP and Kuvshinoff, BW and Malafa, MP and Muscarella, P and Nakakura, EK and Sasson, AR and Thayer, SP and Tyler, DS and NCCN Pancreatic Adenocarcinoma
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, ISSN 1540-1405, 09/2010, Volume 8, Issue 9, pp. 972 - 972
An estimated 36,800 people will die of pancreatic cancer in the United States in 2010. This disease is the fourth most common cause of cancer-related death... 
PROSPECTIVE RANDOMIZED-TRIAL | ductal carcinoma | ultrasonography | DOSE RATE GEMCITABINE | LONG-TERM SURVIVAL | PREOPERATIVE BILIARY DRAINAGE | adenocarcinoma | GEMCITABINE-BASED CHEMORADIATION | NCCN Clinical Practice Guidelines | PORTAL-VEIN CONFLUENCE | endoscopic retrograde cholangiopancreatography | PHASE-III TRIAL | EXTENDED RETROPERITONEAL LYMPHADENECTOMY | ONCOLOGY | pancreas | NCCN Guidelines | gemcitabine | IN-HOSPITAL MORTALITY | COOPERATIVE-ONCOLOGY-GROUP | Adenocarcinoma - diagnosis | Genetic Predisposition to Disease | Adenocarcinoma - therapy | Pancreatic Neoplasms - diagnosis | Humans | Risk Factors | Pancreatic Neoplasms - genetics | Adenocarcinoma - genetics | Pancreatic Neoplasms - therapy
Journal Article
Details down arrow
3. Full Text Resected adenocarcinoma of the pancreas—616 patients: results, outcomes, and prognostic indicators
by Sohn, Taylor A and Yeo, Charles J and Cameron, John L and Koniaris, Leonidas and Kaushal, Sunjay and Abrams, Ross A and Sauter, Patricia K and Coleman, JoAnn and Hruban, Ralph H and Lillemoe, Keith D
Journal of Gastrointestinal Surgery, ISSN 1091-255X, 2000, Volume 4, Issue 6, pp. 567 - 579
This large-volume, single-institution review examines factors influencing long-term survival after resection in patients with adenocarcinoma of the head, neck,... 
adenocarcinoma | prognostic factors | Pancreatic cancer | survival | Medicine & Public Health | Surgery | Gastroenterology | Adenocarcinoma | Survival | Prognostic factors | SURGERY | LONG-TERM SURVIVAL | CURATIVE RESECTION | 5-YEAR SURVIVORS | PROSPECTIVE-RANDOMIZED TRIAL | K-RAS MUTATIONS | pancreatic cancer | CONSECUTIVE PANCREATICODUODENECTOMIES | HOSPITAL VOLUME | PERIAMPULLARY ADENOCARCINOMA | WHIPPLE PROCEDURE | ADJUVANT RADIOTHERAPY | GASTROENTEROLOGY & HEPATOLOGY | Multivariate Analysis | Confidence Intervals | Pancreaticoduodenectomy - mortality | Prognosis | Pancreatic Neoplasms - diagnosis | Humans | Middle Aged | Male | Pancreaticoduodenectomy - methods | Female | Retrospective Studies | Radiotherapy, Adjuvant | Adenocarcinoma - radiotherapy | Maryland - epidemiology | Pancreatic Neoplasms - surgery | Risk Factors | Hospitals, University | Proportional Hazards Models | Pancreatic Neoplasms - radiotherapy | Treatment Outcome | Pancreatectomy - mortality | Adenocarcinoma - diagnosis | Analysis of Variance | Survival Analysis | Aged | Adenocarcinoma - surgery | Cohort Studies | Pancreatectomy - methods | Confidence intervals | Multivariate analysis | Pancreas | Medical treatment | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Pancreatic Ductal Adenocarcinoma is Spread to the Peripancreatic Soft Tissue in the Majority of Resected Cases, Rendering the AJCC T-Stage Protocol (7th Edition) Inapplicable and Insignificant: A Size-Based Staging System (pT1: ≤2, pT2: >2–≤4, pT3: >4 cm) is More Valid and Clinically Relevant
by Saka, Burcu and Balci, Serdar and Basturk, Olca and Bagci, Pelin and Postlewait, Lauren M and Maithel, Shishir and Knight, Jessica and El-Rayes, Bassel and Kooby, David and Sarmiento, Juan and Muraki, Takashi and Oliva, Irma and Bandyopadhyay, Sudeshna and Akkas, Gizem and Goodman, Michael and Reid, Michelle D and Krasinskas, Alyssa and Everett, Rhonda and Adsay, Volkan
Annals of Surgical Oncology, ISSN 1068-9265, 6/2016, Volume 23, Issue 6, pp. 2010 - 2018
Most studies have failed to identify any prognostic value of the current T-stage protocol for pancreatic ductal adenocarcinoma (PDAC) by the American Joint... 
Oncology | Medicine & Public Health | Surgical Oncology | Surgery | Adenocarcinoma - pathology | Prospective Studies | Follow-Up Studies | Humans | Middle Aged | Pancreatic Neoplasms - pathology | Pancreatic Neoplasms - surgery | Male | Survival Rate | Lymphatic Metastasis | Carcinoma, Pancreatic Ductal - pathology | Carcinoma, Pancreatic Ductal - surgery | Aged, 80 and over | Adult | Female | Aged | Neoplasm Staging | Adenocarcinoma - surgery | Adenocarcinoma | Pancreatic cancer | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma
by Raphael, Benjamin J and Hruban, Ralph H and Aguirre, Andrew J and Moffitt, Richard A and Yeh, Jen Jen and Stewart, Chip and Robertson, A. Gordon and Cherniack, Andrew D and Gupta, Manaswi and Getz, Gad and Gabriel, Stacey B and Meyerson, Matthew and Cibulskis, Carrie and Fei, Suzanne S and Hinoue, Toshinori and Shen, Hui and Laird, Peter W and Ling, Shiyun and Lu, Yiling and Mills, Gordon B and Akbani, Rehan and Loher, Phillipe and Londin, Eric R and Rigoutsos, Isidore and Telonis, Aristeidis G and Gibb, Ewan A and Goldenberg, Anna and Mezlini, Aziz M and Hoadley, Katherine A and Collisson, Eric and Lander, Eric and Murray, Bradley A and Hess, Julian and Rosenberg, Mara and Bergelson, Louis and Zhang, Wei and Zhang, Hailei and Zhang, Jiashan (Julia) and Zhang, Lizhi and Cho, Juok and Tiao, Grace and Kim, Seong Hoon and Kim, Hark and Kim, Jaegil and Kim, Paula and Kim, Yong Hoon and Livitz, Dimitri and Leshchiner, Ignaty and Reardon, Brendan and Van Allen, Eliezer and Kamburov, Atanas and Beroukhim, Rameen and Saksena, Gordon and Schumacher, Steven E and Noble, Michael S and Heiman, David I and Gehlenborg, Nils and Lawrence, Michael S and Adsay, Volkan and Petersen, Gloria and Klimstra, David and Bardeesy, Nabeel and Leiserson, Mark D.M and Bowlby, Reanne and Kasaian, Katayoon and Birol, Inanc and Mungall, Andrew J and Mungall, Karen L and Sadeghi, Sara and Weinstein, John N and Spellman, Paul T and Liu, Yuexin and Liu, Jia and Amundadottir, Laufey T and Tepper, Joel and Singhi, Aatur D and Dhir, Rajiv and Paul, Drwiega and Smyrk, Thomas and Bowen, Jay and Frick, Jessica and Gastier-Foster, Julie M and Gerken, Mark and Lau, Kevin and Leraas, Kristen M and Lichtenberg, Tara M and Ramirez, Nilsa C and Renkel, Jeremy and Sherman, Mark and Wise, Lisa and Yena, Peggy and Zmuda, Erik and Shih, Juliann and Ally, Adrian and Balasundaram, Miruna and Carlsen, Rebecca and Chu, Andy and Chuah, Eric and Clarke, Amanda and Dhalla, Noreen and ... and Canc Genome Atlas Res Network and Cancer Genome Atlas Research Network. Electronic address: andrew_aguirre@dfci.harvard.edu and Cancer Genome Atlas Research Network
Cancer Cell, ISSN 1535-6108, 08/2017, Volume 32, Issue 2, pp. 185 - 203.e13
We performed integrated genomic, transcriptomic, and proteomic profiling of 150 pancreatic ductal adenocarcinoma (PDAC) specimens, including samples with... 
molecular subtypes | pancreatic cancer | PDAC | tumor cellularity | genomics | miRNA | RPPA | KRAS | heterogeneity | TCGA | PHASE PROTEIN ARRAY | HEREDITARY PANCREATITIS | CANCER GENES | LONG NONCODING RNA | DNA METHYLATION | ONCOLOGY | HNF1A-AS1 REGULATES PROLIFERATION | MUTATIONAL LANDSCAPE | TUMOR-SUPPRESSOR | COPY-NUMBER ALTERATION | SEQUENCING REVEALS | CELL BIOLOGY | Pancreatic Neoplasms - metabolism | Proto-Oncogene Proteins p21(ras) - genetics | Humans | Carcinoma, Pancreatic Ductal - metabolism | Gene Expression Regulation, Neoplastic | Pancreatic Neoplasms - genetics | Gene Expression Profiling | Transcriptome - genetics | Proteome - analysis | Mutation - genetics | Carcinoma, Pancreatic Ductal - genetics | DNA Methylation | Epigenesis, Genetic - genetics | Genomics - methods | Adenocarcinoma | RNA | Analysis | Pancreatic cancer | Genomics | Stem cells | Genetic aspects | Tumor proteins | Transforming growth factors | Cancer | MicroRNA | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Pancreatic Adenocarcinoma
by Moyer, MT and Gaffney, RR
NEW ENGLAND JOURNAL OF MEDICINE, ISSN 0028-4793, 11/2014, Volume 371, Issue 22, pp. 2140 - 2140
MEDICINE, GENERAL & INTERNAL | CYSTS | Adenocarcinoma | Pancreatic Neoplasms | Humans
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Pancreatic Adenocarcinoma
by Bükki, Johannes and Moyer, Matthew T and Gaffney, Ryan R and Ryan, David P and Hong, Theodore S and Bardeesy, Nabeel
The New England Journal of Medicine, ISSN 0028-4793, 11/2014, Volume 371, Issue 22, pp. 2139 - 2141
To the Editor: In their review of pancreatic adenocarcinoma, Ryan and colleagues (Sept. 11 issue) 1 only briefly mention the issue of symptom control. However,... 
TRIAL | MEDICINE, GENERAL & INTERNAL | CANCER | GEMCITABINE | Adenocarcinoma | Pancreatic Neoplasms | Humans | Anorexia | Pain | Dyspnea | Gemcitabine | Fatigue | Cachexia | Anxiety | Nausea | Pancreas | Respiration | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Pancreatic Adenocarcinoma: Number of Positive Nodes Allows to Distinguish Several N Categories
by Strobel, Oliver and Hinz, Ulf and Gluth, Alexander and Hank, Thomas and Hackert, Thilo and Bergmann, Frank and Werner, Jens and Büchler, Markus W
Annals of Surgery, ISSN 0003-4932, 05/2015, Volume 261, Issue 5, pp. 961 - 969
OBJECTIVE:To determine the prognostic value of PLN and LNR based on a large series with standardized lymphadenectomy and pathological workup. BACKGROUND:Lymph... 
pancreatoduodenectomy | lymph node ratio | pancreatic cancer | survival | number of positive nodes | staging | lymph node involvement | PANCREATICODUODENECTOMY | SURGERY | DUCTAL ADENOCARCINOMA | RESECTION | RATIO | CANCER | PREDICTION | IMPACT | IMPORTANT PROGNOSTIC-FACTOR | Lymph Node Excision | Adenocarcinoma - pathology | Lymph Nodes - pathology | Prognosis | Prospective Studies | Follow-Up Studies | Humans | Middle Aged | Pancreatic Neoplasms - pathology | Male | Pancreaticoduodenectomy | Chemoradiotherapy, Adjuvant | Adenocarcinoma - therapy | Survival Analysis | Neoadjuvant Therapy | Aged | Pancreatic Neoplasms - mortality | Chemotherapy, Adjuvant | Neoplasm Staging | Adenocarcinoma - mortality | Pancreatic Neoplasms - therapy | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Long-term survival after pancreatoduodenectomy for pancreatic adenocarcinoma is cure possible?
by Schnelldorfer, Thomas and Ware, Adam L and Sarr, Michael G and Smyrk, Thomas C and Zhang, Lizhi and Qin, Rui and Gullerud, Rachel E and Donohue, John H and Nagorney, David M and Farnell, Michael B
Annals of Surgery, ISSN 0003-4932, 03/2008, Volume 247, Issue 3, pp. 456 - 462
Objective: To determine long-term survival after pancreatoduodenectomy for pancreatic ductal adenocarcinoma and to identify clinical factors associated with... 
TRIAL | SURGERY | POPULATION | SINGLE | PROGNOSTIC-FACTORS | DUCTAL ADENOCARCINOMA | CURATIVE RESECTION | 5-YEAR SURVIVORS | EXPERIENCE | CANCER | CHEMOTHERAPY | Multivariate Analysis | Adenocarcinoma - pathology | Prognosis | Follow-Up Studies | Humans | Middle Aged | Pancreatic Neoplasms - pathology | Pancreatic Neoplasms - surgery | Male | Survival Rate | Pancreaticoduodenectomy | Serum Albumin - analysis | Case-Control Studies | Adenocarcinoma - therapy | Aged, 80 and over | Adult | Female | Aged | Pancreatic Neoplasms - mortality | Chemotherapy, Adjuvant | Radiotherapy, Adjuvant | Adenocarcinoma - mortality | Adenocarcinoma - surgery | Pancreatic Neoplasms - therapy | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Total Laparoscopic Pancreaticoduodenectomy for Pancreatic Ductal Adenocarcinoma: Oncologic Advantages Over Open Approaches?
by Croome, Kristopher P and Farnell, Michael B and Que, Florencia G and Reid-Lombardo, KMarie and Truty, Mark J and Nagorney, David M and Kendrick, Michael L
Annals of Surgery, ISSN 0003-4932, 10/2014, Volume 260, Issue 4, pp. 633 - 640
OBJECTIVE:To directly compare the oncologic outcomes of TLPD and OPD in the setting of pancreatic ductal adenocarcinoma. BACKGROUND:Total laparoscopic... 
Chemotherapy | cancer | Whipple | Pancreaticoduodenectomy | Laparoscopic | ADJUVANT CHEMOTHERAPY | SURGERY | SURVIVAL | RESECTION | laparoscopic | TIME | chemotherapy | INTERNATIONAL STUDY-GROUP | pancreaticoduodenectomy | LIVER | OUTCOMES | Length of Stay | Laparoscopy - mortality | Pancreaticoduodenectomy - mortality | Humans | Middle Aged | Pancreatic Neoplasms - surgery | Male | Pancreaticoduodenectomy - adverse effects | Carcinoma, Pancreatic Ductal - surgery | Robotics | Pancreaticoduodenectomy - methods | Blood Loss, Surgical | Disease-Free Survival | Laparoscopy - methods | Laparoscopy - adverse effects | Time Factors | Female | Neoadjuvant Therapy | Aged | Retrospective Studies | Chemotherapy, Adjuvant | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Failure to Adhere to Protocol Specified Radiation Therapy Guidelines Was Associated With Decreased Survival in RTOG 9704—A Phase III Trial of Adjuvant Chemotherapy and Chemoradiotherapy for Patients With Resected Adenocarcinoma of the Pancreas
by Abrams, Ross A., M.D and Winter, Kathryn A., M.S and Regine, William F., M.D and Safran, Howard, M.D and Hoffman, John P., M.D and Lustig, Robert, M.D and Konski, Andre A., M.D and Benson, Al B., M.D and Macdonald, John S., M.D and Rich, Tyvin A., M.D and Willett, Christopher G., M.D
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2012, Volume 82, Issue 2, pp. 809 - 816
Purpose In Radiation Therapy Oncology Group 9704, as previously published, patients with resected pancreatic adenocarcinoma received continuous infusion 5-FU... 
Radiology | Hematology, Oncology and Palliative Medicine | Pancreatic adenocarcinoma | Quality assurance | Radiotherapy | Chemoradiotherapy | Adjuvant therapy | CANCER PATIENTS | QUALITY | STAGE | POSTOPERATIVE RADIOTHERAPY | RANDOMIZED-TRIAL | CELL CARCINOMA | GEMCITABINE | BREAST-CANCER | RECTAL-CANCER | HOSPITAL VOLUME | ONCOLOGY | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Multivariate Analysis | Chemoradiotherapy - adverse effects | Adenocarcinoma - pathology | Humans | Middle Aged | Male | Fluorouracil - therapeutic use | Deoxycytidine - therapeutic use | Fluorouracil - adverse effects | Chemotherapy, Adjuvant - adverse effects | Aged, 80 and over | Adult | Deoxycytidine - adverse effects | Female | Pancreatic Neoplasms - mortality | Chemoradiotherapy - methods | Pancreatic Neoplasms - pathology | Antimetabolites, Antineoplastic - therapeutic use | Guideline Adherence | Adenocarcinoma - therapy | Survival Analysis | Aged | Deoxycytidine - analogs & derivatives | Adenocarcinoma - mortality | Pancreatic Neoplasms - therapy | Adenocarcinoma | Care and treatment | Nuclear radiation | Pancreatic cancer | Patient outcomes | Analysis | Adjuvant treatment | Clinical trials | Cancer | Index Medicus | HEAD | PATIENTS | QUALITY ASSURANCE | FAILURES | PANCREAS | INFUSION | TOXICITY | CHEMOTHERAPY | MULTIVARIATE ANALYSIS | RECOMMENDATIONS | CARCINOMAS | RADIOLOGY AND NUCLEAR MEDICINE | RADIOTHERAPY | COMBINED THERAPY | HAZARDS | pancreatic adenocarcinoma | adjuvant therapy | chemoradiotherapy | quality assurance
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights